Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Sidus Space (SIDU) Stock Soars 180% on NASA News

Today, investors in SIDU stock are cheering an announced contract that provides revenue potential for Sidus Space.

Rivian Stock Warning: Could the EV Startup Really Go Bankrupt?

Today's 75 basis point interest rate hike appears to have investors in beaten-up Rivian stock looking on the bright side.

Goodbye DIDI Stock, Hello DIDIY! Ride-Hailing Giant Starts Trading on OTC Markets.

Today marks the first day of trading for DIDI under its new DIDIY stock ticker on the over the counter exchange - here's what to know.

VOO ETF: What Is Going on With the Vanguard 500 Index Fund Today?

Is now the time to buy the VOO ETF, or is a better strategy to sit on the sidelines and wait out this volatility? Let's take a closer look.

Why Is Day One Biopharmaceuticals (DAWN) Stock Up 103% Today?

Today's announcement of positive clinical trial results for a key pediatric tumor drug has DAWN stock more than doubling on Monday.